• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR G4 STEERABLE GUIDING CATHETER; CATHETER, STEERABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR G4 STEERABLE GUIDING CATHETER; CATHETER, STEERABLE Back to Search Results
Catalog Number SGC0705
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Hematoma (1884); Hemorrhage/Bleeding (1888); Low Blood Pressure/ Hypotension (1914); Inflammation (1932); Tachycardia (2095)
Event Date 03/09/2022
Event Type  Injury  
Event Description
This is filed to report hematoma, tachycardia, hypotension, delay, medical intervention, and prolonged hospitalization.It was reported that this was a mitraclip procedure to treat functional mitral regurgitation (mr) with a grade of 3+.The steerable guide catheter (sgc) was advanced to the septum without issue.However, after the clip delivery system (cds) was inserted and the straddle position was reached, the patient's blood pressure began to slowly drop and the lower abdomen became swollen.Hematoma was in the bladder.Contrast was performed from the sheath of the left inguinal region.Bleeding was confirmed in the abdominal cavity, but the bleeding point was not confirmed.This caused a clinically significant delay in the procedure.Since blood pressure was at 60-70 range, a decision was made to remove the sgc and cds from the patient and test for the bleeding point.Medication was administered and then the blood pressure dropped to 50 and the heart rate was at 130.A blood transfusion was performed with administration of blood products.Then an intra-aortic balloon pump (iabp) was inserted from the left inguinal region and a detailed computed tomography(ct) was performed.The bleeding site still remained unknown; however, the physician stated the sgc may have caused the clinical outcomes.The patient's general condition improved; and therefore the iabp was removed.The mitraclip procedure was aborted and no clips were implanted, mr is 3+.The patient remained hospitalized longer.The next day, a contrast-enhanced catheter was performed, but the bleeding point was still unknown.The patient will be scheduled for a follow-up.No other information was provided.
 
Manufacturer Narrative
The device will not be returned for evaluation, the device was reportedly discarded.Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
 
Manufacturer Narrative
The device was not returned for evaluation.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to the reported event.Based on the information reviewed, a cause for the reported hematoma and hemorrhage resulting in hypotension, inflammation and tachycardia cannot be determined.Hematoma, hypotension, inflammation, hemorrhage and tachycardia are listed in the instructions for use (ifu) as known possible complications associated with mitraclip procedures.The reported medication required, unexpected medical interventions, delay to treatment/therapy and hospitalization were a result of case-specific circumstances.There is no indication of a product issue with respect to manufacture, design or labeling.
 
Event Description
N/a.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
G4 STEERABLE GUIDING CATHETER
Type of Device
CATHETER, STEERABLE
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 3005070406
3885 bohannon drive
menlo park CA 94025
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key13965585
MDR Text Key288289953
Report Number2024168-2022-03396
Device Sequence Number1
Product Code DRA
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
K190167
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 06/02/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/31/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date09/30/2022
Device Catalogue NumberSGC0705
Device Lot Number11001R148
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received05/10/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured10/01/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
CLIP DELIVERY SYSTEM
Patient Outcome(s) Required Intervention; Hospitalization;
Patient Age70 YR
Patient SexFemale
Patient Weight45 KG
-
-